The German drugmaker will pay the NIH $791.5 million, while the University of Pennsylvania will get up to $467 million ...

The University of Pennsylvania expects to receive $467 million from a German COVID-19 vaccine manufacturer after the pair ...

University of Pennsylvania will receive $467 million from BioNTech as part of a settlement in a lawsuit over COVID-19 vaccine royalties, writes John George ...

Also, Penn settled a lawsuit with the German drug manufacturer BioNTech, which, with Pfizer, made the COVID vaccine using ...

Animal testing of the vaccine by the team at the University of Pennsylvania's Perelman School ... Meanwhile, mRNA vaccine heavyweights Pfizer/BioNTech and Moderna are also working on novel shots ...

2024 BioNTech has entered into two separate settlement agreements with the U.S. National Institutes of Health and the University of Pennsylvania over the payment of royalties related to its COVID ...

Penn cell therapy spinout Verismo Therapeutics has a new owner. Here's how the deal came together and why everyone is telling ...

WuXi AppTec, the Shanghai-based biotech giant, has sold its South Philly-based WuXi Advanced Therapies contract manufacturing ...

Morgan Stanley analyst Terence Flynn maintained a Buy rating on BioNTech SE (BNTX – Research Report) today and set a price target of $145.00.

PITTSBURGH (KDKA) - University of Pittsburgh researchers have developed a new nasal swab test to determine Asthma subtype results for kids. The study which was conducted by Dr. Juan Celedón a ...

Sangamo shares fell on Pfizer’s decision to hand back rights to a hemophilia gene therapy. Elsewhere, Novartis got ...